
NYSEHealthcareMedical - Devices
أحدث البيانات المتاحة
317.52 US$
+1.17 US$ · +0.37%
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
الإغلاق السابق
317.52 US$
+1.17 US$ · +0.37%
بعد ساعات التداول
317.52 US$
0.00 US$ · 0.00%
8 أكتوبر، 5:07 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
نطاق اليوم
السعر الحالي 317.52 US$
نطاق 52 أسبوعًا
السعر الحالي 317.52 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
33
مرتفع السعر
المشاعر
47
مختلط
المخاطر
14
مخاطر منخفضة
الزخم
42
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
نطاق اليوم
السعر الحالي 317.52 US$
نطاق 52 أسبوعًا
السعر الحالي 317.52 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 1.4 مليار USD | 1.19 مليار USD | 1.06 مليار USD | 847.13 مليون USD | 747.59 مليون USD |
| تكلفة البضاعة المباعة | 461.23 مليون USD | 439.62 مليون USD | 375.88 مليون USD | 311.93 مليون USD | 272.21 مليون USD |
| الربح الإجمالي | 942.44 مليون USD | 755 مليون USD | 682.64 مليون USD | 535.21 مليون USD | 475.38 مليون USD |
| البحث والتطوير | 89.77 مليون USD | 94.78 مليون USD | 84.42 مليون USD | 79.41 مليون USD | 104.55 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 663.42 مليون USD | 573.99 مليون USD | 506.45 مليون USD | 449.72 مليون USD | 378.33 مليون USD |
| نفقات التشغيل | 753.19 مليون USD | 668.77 مليون USD | 609.09 مليون USD | 529.13 مليون USD | 482.88 مليون USD |
| دخل الفوائد | 16.29 مليون USD | 13.69 مليون USD | 6.83 مليون USD | 1.89 مليون USD | 2.87 مليون USD |
| مصاريف الفوائد | 1.31 مليون USD | 1.42 مليون USD | 1.74 مليون USD | 1.75 مليون USD | 1.93 مليون USD |
| الاستهلاك والإطفاء | 17.47 مليون USD | 23.7 مليون USD | 27.26 مليون USD | 24.32 مليون USD | 16.41 مليون USD |
| الدخل التشغيلي | 189.25 مليون USD | 86.22 مليون USD | 73.55 مليون USD | 6.08 مليون USD | −7.5 مليون USD |
| صافي الدخل | 177.69 مليون USD | 14.01 مليون USD | 90.95 مليون USD | −2 مليون USD | 5.28 مليون USD |
تم تحديث حقائق الشركة 9 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
320 US$
ارتفاع محتمل بنسبة 0.78%| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 16 نوفمبر 2014 | 1:10 | — | — |
ساري 16 نوفمبر 2014
1:10
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI383.08 مليون0.02%2.3 ترليون USD0.03%379.56 US$-0.39%
Vanguard Morningstar Small-Cap ETFVB277.68 مليون0.15%185.3 مليار USD0.03%287.63 US$+0.23%
Vanguard Morningstar Small-Cap Growth ETFVBK159.42 مليون0.35%44.7 مليار USD0.05%340.59 US$-0.48%
Vanguard Extended Market ETFVXF147.54 مليون0.15%95.4 مليار USD0.05%233.13 US$-0.15%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY94.37 مليون0.36%25.53 مليار USD0.23%666.26 US$+0.35%
iShares Russell Mid-Cap Growth ETFIWP67.84 مليون0.34%19.88 مليار USD0.23%140.9 US$-0.40%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD67.62 مليون0.37%18.2 مليار USD0.03%63.97 US$+0.33%
iShares U.S. Medical Devices ETFIHI61.83 مليون1.75%3.53 مليار USD0.37%51.10 US$+0.29%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Growth ETFVBK
Vanguard Extended Market ETFVXF
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
iShares Russell Mid-Cap Growth ETFIWP
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD
iShares U.S. Medical Devices ETFIHIالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.